Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 13/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13023985 | 0.93 | PIM1 (0.34) | PIM1MAPTRAPGEF4MEN1KMT2A | |
| SCHEMBL13023991 | 0.93 | RAPGEF4 (0.32) | MAPTRAPGEF4MEN1KMT2A | |
| SCHEMBL13023971 | 0.93 | MAPT (0.35) | PIM1MAPTRAPGEF4MEN1KMT2A | |
| SCHEMBL13023978 | 0.89 | MAPT (0.36) | PIM1MAPTRAPGEF4 | |
| SCHEMBL13023975 | 0.87 | RAPGEF4 (0.34) | MAPTRAPGEF4MEN1KMT2A | |
| SCHEMBL13023983 | 0.86 | MAPT (0.38) | MAPT | |
| SCHEMBL13023980 | 0.83 | MAPT (0.36) | MAPTRAPGEF4 | |
| SCHEMBL13024001 | 0.83 | MAPT (0.30) | MAPT | |
| SCHEMBL13024009 | 0.82 | PIM1 (0.31) | PIM1 | |
| SCHEMBL13024006 | 0.80 | PIM1 (0.32) | PIM1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-11 | — | — | US | disclosed |
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | IGF1R, SCO2, CRY1 | PIM1 33/4885MAPT 2367/4885RAPGEF4 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.